Following transcardial perfusion with 4% paraformaldehyde (PFA) in 0.01 m PBS, brains were postfixed overnight in chilled perfusion solution before being transferred to 0.01 m PBS. 50-μm coronal slices were cut the following day on a vibratome, then washed three times and stored in 0.01 m PBS with 0.05% NaN3 at 4°C until staining.
Slices were rinsed three times in 0.01 m PBS, then incubated in the primary antibody solution overnight (0.3% Triton X-100, 0.05% NaN3, 1% BSA, and primary antibody in 0.01 m PBS). The following day, slices were rinsed three times in 0.01 m PBS, then incubated in the secondary antibody solution for 2 h (1% BSA and secondary antibody in 0.01 m PBS). Slices were then mounted on a glass slide with an anti-fade medium (Fluoromount-G), coverslipped, and allowed to dry overnight. Images were taken on a Leica SP5 confocal microscope. Image stacks with 488-, 543-, and 647-nm lasers were obtained using a 20× objective with an optical section height (z-step) of ∼2 μm. Images were subsequently analyzed in ImageJ.
We used the following antibodies:
anti-CaMKIV (1:1000, Santa Cruz Biotechnology sc-136249, RRID:AB_2275109),
anti-CaMKIV (1:1000, Sigma C2851, RRID:AB_258821),
anti-CaMKIV (1:1000, BD Biosciences 610275, RRID:AB_397670),
anti-pCaMKIV (1:200, Santa Cruz Biotechnology sc-28443-R, RRID:AB_2068399),
anti-VGlut2 (1:10000, Millipore AB2251, RRID:AB_1587626),
Goat anti-Mouse IgG Alexa Fluor 555 (1:300, Thermo Fisher A-21424, RRID:AB_141780),
Goat anti-Rabbit IgG Alexa Fluor 488 (1:300, Thermo Fisher A-11034, RRID:AB_2576217),
Goat anti-Guinea Pig IgG Alexa Fluor 647 (1:300, Thermo Fisher A-21450, RRID:AB_2735091).
When using the polyclonal phospho-CaMKIV (T196) antibody (sc-28443-R, Santa Cruz Biotechnology), we did not observe any difference in staining between wild-type and conditional CaMKIV knock-down mice. This suggests that the Santa Cruz Biotechnology sc-28443-R antibody, when used for immunostaining, is not specific for pCaMKIV. We attempted to immunolabel phospho-CaMKIV with antibodies obtained from multiple other sources with no success.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.